Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-227245
Filing Date
2026-05-15
Accepted
2026-05-15 17:20:35
Documents
70
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hura-20260331.htm   iXBRL 10-Q 1488500
2 EX-10.1 hura-ex10_1.htm EX-10.1 56389
3 EX-10.2 hura-ex10_2.htm EX-10.2 77075
4 EX-31.1 hura-ex31_1.htm EX-31.1 17763
5 EX-31.2 hura-ex31_2.htm EX-31.2 17757
6 EX-32.1 hura-ex32_1.htm EX-32.1 10177
7 EX-32.2 hura-ex32_2.htm EX-32.2 10101
  Complete submission text file 0001193125-26-227245.txt   7797907

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hura-20260331.xsd EX-101.SCH 1812530
74 EXTRACTED XBRL INSTANCE DOCUMENT hura-20260331_htm.xml XML 967482
Mailing Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612
Business Address 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 813-875-6600
TuHURA Biosciences, Inc./NV (Filer) CIK: 0001498382 (see all company filings)

EIN.: 990360497 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 26989833
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)